PL343494A1 - Treatment of generalized anxiety disorder with paroxetine - Google Patents

Treatment of generalized anxiety disorder with paroxetine

Info

Publication number
PL343494A1
PL343494A1 PL99343494A PL34349499A PL343494A1 PL 343494 A1 PL343494 A1 PL 343494A1 PL 99343494 A PL99343494 A PL 99343494A PL 34349499 A PL34349499 A PL 34349499A PL 343494 A1 PL343494 A1 PL 343494A1
Authority
PL
Poland
Prior art keywords
paroxetine
treatment
anxiety disorder
generalized anxiety
generalized
Prior art date
Application number
PL99343494A
Inventor
Rocco Zaninelli
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PL343494A1 publication Critical patent/PL343494A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL99343494A 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine PL343494A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment
PCT/US1999/008786 WO1999053919A1 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Publications (1)

Publication Number Publication Date
PL343494A1 true PL343494A1 (en) 2001-08-27

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99343494A PL343494A1 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Country Status (20)

Country Link
EP (1) EP1073437A4 (en)
JP (1) JP2002512189A (en)
KR (1) KR20010034817A (en)
CN (1) CN1298301A (en)
AP (1) AP2000001959A0 (en)
AU (1) AU3864899A (en)
BG (1) BG104939A (en)
BR (1) BR9909791A (en)
CA (1) CA2328896A1 (en)
CZ (1) CZ20003885A3 (en)
EA (1) EA200001088A1 (en)
GB (1) GB9808479D0 (en)
HU (1) HUP0101350A3 (en)
ID (1) ID27546A (en)
IL (1) IL139167A0 (en)
NO (1) NO20005286L (en)
PL (1) PL343494A1 (en)
SK (1) SK15672000A3 (en)
TR (1) TR200003082T2 (en)
WO (1) WO1999053919A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550C2 (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
GB9808479D0 (en) 1998-06-17
JP2002512189A (en) 2002-04-23
AP2000001959A0 (en) 2000-12-31
NO20005286D0 (en) 2000-10-20
WO1999053919A1 (en) 1999-10-28
EP1073437A4 (en) 2003-04-16
BG104939A (en) 2001-09-28
EA200001088A1 (en) 2001-04-23
HUP0101350A3 (en) 2002-06-28
IL139167A0 (en) 2001-11-25
AU3864899A (en) 1999-11-08
NO20005286L (en) 2000-12-20
CA2328896A1 (en) 1999-10-28
EP1073437A1 (en) 2001-02-07
SK15672000A3 (en) 2001-04-09
CZ20003885A3 (en) 2001-09-12
CN1298301A (en) 2001-06-06
KR20010034817A (en) 2001-04-25
ID27546A (en) 2001-04-12
HUP0101350A2 (en) 2002-05-29
TR200003082T2 (en) 2001-01-22
BR9909791A (en) 2000-12-26

Similar Documents

Publication Publication Date Title
EP1200086A4 (en) Methods for treating or preventing pain and anxiety
GB2337763B (en) Methods of treating preform elements
HK1047693A1 (en) Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof
IL134718A0 (en) Treatment of conduct disorder
EP0996433A4 (en) Methods for treatment of conditions associated with lactosylceramide
GB9905275D0 (en) Treatment of conditions associated with membrane-bound receptors and their function
EP1117395A4 (en) Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
EP1071339A4 (en) Treatment of animals with dihydroxyquinoline compounds
EP1187604A4 (en) Compounds and methods for the treatment of post traumatic stress disorder
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
HUP0102886A2 (en) Treatment of anxiety disorders
IL139167A0 (en) Treatment of generalized anxiety disorder with paroxetine
IL126681A0 (en) Treatment of trauma-related conditions
IL149533A0 (en) Treatment of sle with dehydropiandrosterone
PL345261A1 (en) Method of treatment
HU9904062D0 (en) Fixing rail with holes and process for making of fixing rail
GB2365419B (en) Treatment of effluents
GB9917590D0 (en) Treatment of fibres
GB9819800D0 (en) Treatment of fibres
GB9818295D0 (en) Treatment of alopecia
GB9822681D0 (en) Method of treatment
SI1117403T1 (en) Mglur5 antagonists for the treatment of pain and anxiety
GB9800707D0 (en) Methods of treatment
GB9822458D0 (en) Methods of treatment
GB9824208D0 (en) Methods of treatment

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)